Literature DB >> 22544192

Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.

Esorom Daoni1, Urarang Kitur, Apa Parunga, Fabian Ndenzako, Agatha Lloyd, Dongbao Yu.   

Abstract

In 2009, World Health Organization human immunodeficiency virus drug resistance early warning indicator monitoring was piloted at 2 large antiretroviral therapy (ART) clinics in Papua New Guinea: Heduru Clinic in Port Moresby and Tininga Clinic in Mount Hagen. Results demonstrated that both Heduru and Tininga clinics met internationally suggested targets for prescribing appropriate first-line ART regimens in accordance with national ART guidelines, retention on first-line ART at 12 months, and drug supply continuity. However, both clinics failed to achieve suggested targets for rates of loss to follow-up and on-time pill pickup. Reasons for poor clinic performance on loss to follow-up and on-time pill pickup were explored, and appropriate corrective actions were implemented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544192     DOI: 10.1093/cid/cir994

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Authors:  M R Jordan; D E Bennett; M A Wainberg; D Havlir; S Hammer; C Yang; L Morris; M Peeters; A M Wensing; N Parkin; J B Nachega; A Phillips; A De Luca; E Geng; A Calmy; E Raizes; P Sandstrom; C P Archibald; J Perriëns; C M McClure; S Y Hong; J H McMahon; N Dedes; D Sutherland; S Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.

Authors:  Diane E Bennett; Michael R Jordan; Silvia Bertagnolio; Steven Y Hong; Giovanni Ravasi; James H McMahon; Ahmed Saadani; Karen F Kelley
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

3.  HIV drug resistance early warning indicators in Namibia for public health action.

Authors:  Anna Jonas; Justice Gweshe; Milner Siboleka; Michael Deklerk; Michael Gawanab; Alfons Badi; Victor Sumbi; Dawn Pereko; Abraham Blom; Samson Mwinga; Michael R Jordan; Logan Jerger; Kiger Lau; Steven Y Hong
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

4.  Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.

Authors:  Joseph Fokam; Serge C Billong; Anne C Z K Bissek; Etienne Kembou; Pascal Milenge; Ibile Abessouguie; Armand S Nkwescheu; Zephirin Tsomo; Avelin F Aghokeng; Grace D Ngute; Peter M Ndumbe; Vittorio Colizzi; Jean B N Elat
Journal:  BMC Public Health       Date:  2013-04-08       Impact factor: 3.295

5.  Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.

Authors:  Janet Gare; Angela Kelly-Hanku; Claire E Ryan; Matthew David; Petronia Kaima; Ulato Imara; Namarola Lote; Suzanne M Crowe; Anna C Hearps
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

6.  High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea.

Authors:  Evelyn Lavu; Ellan Kave; Euodia Mosoro; Jessica Markby; Eman Aleksic; Janet Gare; Imogen A Elsum; Gideon Nano; Petronia Kaima; Nick Dala; Anup Gurung; Silvia Bertagnolio; Suzanne M Crowe; Mark Myatt; Anna C Hearps; Michael R Jordan
Journal:  PLoS One       Date:  2017-02-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.